Global Opioid Induced Side Effects Treatment Market Research Report 2025(Status and Outlook)

March 2025 | 224 pages | ID: G50DA8DA5B01EN
Bosson Research

Abstracts

Report Overview

Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.

This report provides a deep insight into the global Opioid Induced Side Effects Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioid Induced Side Effects Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioid Induced Side Effects Treatment market in any manner.

Global Opioid Induced Side Effects Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Shionogi

Cubist Pharmaceuticals

SLA Pharma

AstraZeneca

AIKO Biotechnology

Progenics Pharmaceuticals

Market Segmentation (by Type)

Risperidone

Methylphenidate

Cetirizine

Other

Market Segmentation (by Application)

Drug Overdose Treatment

Pain Treatment

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Opioid Induced Side Effects Treatment Market
• Overview of the regional outlook of the Opioid Induced Side Effects Treatment Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioid Induced Side Effects Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Opioid Induced Side Effects Treatment
1.2 Key Market Segments
  1.2.1 Opioid Induced Side Effects Treatment Segment by Type
  1.2.2 Opioid Induced Side Effects Treatment Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Opioid Induced Side Effects Treatment Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Opioid Induced Side Effects Treatment Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Opioid Induced Side Effects Treatment Product Life Cycle
3.3 Global Opioid Induced Side Effects Treatment Sales by Manufacturers (2020-2025)
3.4 Global Opioid Induced Side Effects Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Opioid Induced Side Effects Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Opioid Induced Side Effects Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Opioid Induced Side Effects Treatment Manufacturing Sites, Area Served, Product Type
3.8 Opioid Induced Side Effects Treatment Market Competitive Situation and Trends
  3.8.1 Opioid Induced Side Effects Treatment Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Opioid Induced Side Effects Treatment Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 OPIOID INDUCED SIDE EFFECTS TREATMENT INDUSTRY CHAIN ANALYSIS

4.1 Opioid Induced Side Effects Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Opioid Induced Side Effects Treatment Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Opioid Induced Side Effects Treatment Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET BY REGION

6.1 Global Opioid Induced Side Effects Treatment Market Size by Region
  6.1.1 Global Opioid Induced Side Effects Treatment Market Size by Region
  6.1.2 Global Opioid Induced Side Effects Treatment Market Size Market Share by Region
6.2 Global Opioid Induced Side Effects Treatment Sales by Region
  6.2.1 Global Opioid Induced Side Effects Treatment Sales by Region
  6.2.2 Global Opioid Induced Side Effects Treatment Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Opioid Induced Side Effects Treatment Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Opioid Induced Side Effects Treatment Market Size by Type
7.3 North America Opioid Induced Side Effects Treatment Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Opioid Induced Side Effects Treatment Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Opioid Induced Side Effects Treatment Market Size by Type
8.3 Europe Opioid Induced Side Effects Treatment Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type
9.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Opioid Induced Side Effects Treatment Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Opioid Induced Side Effects Treatment Market Size by Type
10.3 South America Opioid Induced Side Effects Treatment Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Type
11.3 Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Application

12 OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET PRODUCTION BY REGION

12.1 Global Production of Opioid Induced Side Effects Treatment by Region(2020-2025)
12.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Region (2020-2025)
12.3 Global Opioid Induced Side Effects Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Opioid Induced Side Effects Treatment Production
  12.4.1 North America Opioid Induced Side Effects Treatment Production Growth Rate (2020-2025)
  12.4.2 North America Opioid Induced Side Effects Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Opioid Induced Side Effects Treatment Production
  12.5.1 Europe Opioid Induced Side Effects Treatment Production Growth Rate (2020-2025)
  12.5.2 Europe Opioid Induced Side Effects Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Opioid Induced Side Effects Treatment Production (2020-2025)
  12.6.1 Japan Opioid Induced Side Effects Treatment Production Growth Rate (2020-2025)
  12.6.2 Japan Opioid Induced Side Effects Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Opioid Induced Side Effects Treatment Production (2020-2025)
  12.7.1 China Opioid Induced Side Effects Treatment Production Growth Rate (2020-2025)
  12.7.2 China Opioid Induced Side Effects Treatment Production, Revenue, Price and Gross Margin (2020-2025)

13 OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Opioid Induced Side Effects Treatment Sales Market Share by Type (2020-2033)
13.3 Global Opioid Induced Side Effects Treatment Market Size Market Share by Type (2020-2033)
13.4 Global Opioid Induced Side Effects Treatment Price by Type (2020-2033)

14 OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Opioid Induced Side Effects Treatment Market Sales by Application (2020-2033)
14.3 Global Opioid Induced Side Effects Treatment Market Size (M USD) by Application (2020-2033)
14.4 Global Opioid Induced Side Effects Treatment Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Shionogi
  15.1.1 Shionogi Basic Information
  15.1.2 Shionogi Opioid Induced Side Effects Treatment Product Overview
  15.1.3 Shionogi Opioid Induced Side Effects Treatment Product Market Performance
  15.1.4 Shionogi Business Overview
  15.1.5 Shionogi SWOT Analysis
  15.1.6 Shionogi Recent Developments
15.2 Cubist Pharmaceuticals
  15.2.1 Cubist Pharmaceuticals Basic Information
  15.2.2 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Overview
  15.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Market Performance
  15.2.4 Cubist Pharmaceuticals Business Overview
  15.2.5 Cubist Pharmaceuticals SWOT Analysis
  15.2.6 Cubist Pharmaceuticals Recent Developments
15.3 SLA Pharma
  15.3.1 SLA Pharma Basic Information
  15.3.2 SLA Pharma Opioid Induced Side Effects Treatment Product Overview
  15.3.3 SLA Pharma Opioid Induced Side Effects Treatment Product Market Performance
  15.3.4 SLA Pharma Business Overview
  15.3.5 SLA Pharma SWOT Analysis
  15.3.6 SLA Pharma Recent Developments
15.4 AstraZeneca
  15.4.1 AstraZeneca Basic Information
  15.4.2 AstraZeneca Opioid Induced Side Effects Treatment Product Overview
  15.4.3 AstraZeneca Opioid Induced Side Effects Treatment Product Market Performance
  15.4.4 AstraZeneca Business Overview
  15.4.5 AstraZeneca Recent Developments
15.5 AIKO Biotechnology
  15.5.1 AIKO Biotechnology Basic Information
  15.5.2 AIKO Biotechnology Opioid Induced Side Effects Treatment Product Overview
  15.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Product Market Performance
  15.5.4 AIKO Biotechnology Business Overview
  15.5.5 AIKO Biotechnology Recent Developments
15.6 Progenics Pharmaceuticals
  15.6.1 Progenics Pharmaceuticals Basic Information
  15.6.2 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Overview
  15.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Market Performance
  15.6.4 Progenics Pharmaceuticals Business Overview
  15.6.5 Progenics Pharmaceuticals Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Table 4. Global Opioid Induced Side Effects Treatment Market Size by Application (M USD)
Table 5. Opioid Induced Side Effects Treatment Market Size Comparison by Region (M USD)
Table 6. Global Opioid Induced Side Effects Treatment Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Opioid Induced Side Effects Treatment Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Opioid Induced Side Effects Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Opioid Induced Side Effects Treatment Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Side Effects Treatment as of 2024)
Table 11. Global Market Opioid Induced Side Effects Treatment Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Opioid Induced Side Effects Treatment Manufacturing Sites and Area Served
Table 13. Manufacturers Opioid Induced Side Effects Treatment Product Type
Table 14. Global Opioid Induced Side Effects Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Induced Side Effects Treatment Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Opioid Induced Side Effects Treatment Market Size Comparison by Region (M USD)
Table 26. Global Opioid Induced Side Effects Treatment Market Size by Region (2020-2033) & (M USD)
Table 27. Global Opioid Induced Side Effects Treatment Market Size Market Share by Region (2020-2033)
Table 28. Global Opioid Induced Side Effects Treatment Sales by Region (2020-2033) & (K MT)
Table 29. Global Opioid Induced Side Effects Treatment Sales Market Share by Region (2020-2033)
Table 30. North America Opioid Induced Side Effects Treatment Market Size by Country (2020-2033) & (M USD)
Table 31. North America Opioid Induced Side Effects Treatment Sales by Country (2020-2033) & (K MT)
Table 32. North America Opioid Induced Side Effects Treatment Sales by Type (K MT)
Table 33. North America Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Table 34. North America Opioid Induced Side Effects Treatment Sales (K MT) by Type (2020-2033)
Table 35. North America Opioid Induced Side Effects Treatment Market Size (M USD) by Type (2020-2033)
Table 36. North America Opioid Induced Side Effects Treatment Sales by Application (K MT)
Table 37. North America Opioid Induced Side Effects Treatment Market Size by Application (M USD)
Table 38. North America Opioid Induced Side Effects Treatment Sales (K MT) by Application (2020-2033)
Table 39. North America Opioid Induced Side Effects Treatment Market Size (M USD) by Application (2020-2033)
Table 40. Europe Opioid Induced Side Effects Treatment Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Opioid Induced Side Effects Treatment Sales by Country (2020-2033) & (K MT)
Table 42. Europe Opioid Induced Side Effects Treatment Sales by Type (K MT)
Table 43. Europe Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Table 44. Europe Opioid Induced Side Effects Treatment Sales (K MT) by Type (2020-2033)
Table 45. Europe Opioid Induced Side Effects Treatment Market Size (M USD) by Type (2020-2033)
Table 46. Europe Opioid Induced Side Effects Treatment Sales by Application (K MT)
Table 47. Europe Opioid Induced Side Effects Treatment Market Size by Application (M USD)
Table 48. Europe Opioid Induced Side Effects Treatment Sales (K MT) by Application (2020-2033)
Table 49. Europe Opioid Induced Side Effects Treatment Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Opioid Induced Side Effects Treatment Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Opioid Induced Side Effects Treatment Sales by Type (K MT)
Table 53. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Table 54. Asia-Pacific Opioid Induced Side Effects Treatment Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Opioid Induced Side Effects Treatment Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Opioid Induced Side Effects Treatment Sales by Application (K MT)
Table 57. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (M USD)
Table 58. Asia-Pacific Opioid Induced Side Effects Treatment Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Opioid Induced Side Effects Treatment Market Size (M USD) by Application (2020-2025)
Table 60. South America Opioid Induced Side Effects Treatment Market Size by Country (2020-2033) & (M USD)
Table 61. South America Opioid Induced Side Effects Treatment Sales by Country (2020-2033) & (K MT)
Table 62. South America Opioid Induced Side Effects Treatment Sales by Type (K MT)
Table 63. South America Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Table 64. South America Opioid Induced Side Effects Treatment Sales (K MT) by Type (2020-2033)
Table 65. South America Opioid Induced Side Effects Treatment Market Size (M USD) by Type (2020-2033)
Table 66. South America Opioid Induced Side Effects Treatment Sales by Application (K MT)
Table 67. South America Opioid Induced Side Effects Treatment Market Size by Application (M USD)
Table 68. South America Opioid Induced Side Effects Treatment Sales (K MT) by Application (2020-2033)
Table 69. South America Opioid Induced Side Effects Treatment Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Opioid Induced Side Effects Treatment Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Opioid Induced Side Effects Treatment Sales by Type (K MT)
Table 73. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Table 74. Middle East and Africa Opioid Induced Side Effects Treatment Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Opioid Induced Side Effects Treatment Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Opioid Induced Side Effects Treatment Sales by Application (K MT)
Table 77. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Application (M USD)
Table 78. Middle East and Africa Opioid Induced Side Effects Treatment Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Opioid Induced Side Effects Treatment Market Size (M USD) by Application (2020-2033)
Table 80. Global Opioid Induced Side Effects Treatment Production (K MT) by Region(2020-2025)
Table 81. Global Opioid Induced Side Effects Treatment Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Opioid Induced Side Effects Treatment Revenue Market Share by Region (2020-2025)
Table 83. Global Opioid Induced Side Effects Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Opioid Induced Side Effects Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Opioid Induced Side Effects Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Opioid Induced Side Effects Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Opioid Induced Side Effects Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Opioid Induced Side Effects Treatment Sales by Type (K MT)
Table 89. Global Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Table 90. Global Opioid Induced Side Effects Treatment Sales (K MT) by Type (2020-2033)
Table 91. Global Opioid Induced Side Effects Treatment Sales Market Share by Type (2020-2033)
Table 92. Global Opioid Induced Side Effects Treatment Market Size (M USD) by Type (2020-2033)
Table 93. Global Opioid Induced Side Effects Treatment Market Size Share by Type (2020-2033)
Table 94. Global Opioid Induced Side Effects Treatment Sales (K MT) by Application
Table 95. Global Opioid Induced Side Effects Treatment Market Size by Application(M USD)
Table 96. Global Opioid Induced Side Effects Treatment Sales by Application (2020-2033) & (K MT)
Table 97. Global Opioid Induced Side Effects Treatment Sales Market Share by Application (2020-2033)
Table 98. Global Opioid Induced Side Effects Treatment Market Size by Application (2020-2033) & (M USD)
Table 99. Global Opioid Induced Side Effects Treatment Market Share by Application (2020-2033)
Table 100. Global Opioid Induced Side Effects Treatment Sales Growth Rate by Application (2020-2033)
Table 101. Shionogi Basic Information
Table 102. Shionogi Opioid Induced Side Effects Treatment Product Overview
Table 103. Shionogi Opioid Induced Side Effects Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Shionogi Business Overview
Table 105. Shionogi SWOT Analysis
Table 106. Shionogi Recent Developments
Table 107. Cubist Pharmaceuticals Basic Information
Table 108. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Overview
Table 109. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Cubist Pharmaceuticals Business Overview
Table 111. Cubist Pharmaceuticals SWOT Analysis
Table 112. Cubist Pharmaceuticals Recent Developments
Table 113. SLA Pharma Basic Information
Table 114. SLA Pharma Opioid Induced Side Effects Treatment Product Overview
Table 115. SLA Pharma Opioid Induced Side Effects Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. SLA Pharma Business Overview
Table 117. SLA Pharma SWOT Analysis
Table 118. SLA Pharma Recent Developments
Table 119. AstraZeneca Basic Information
Table 120. AstraZeneca Opioid Induced Side Effects Treatment Product Overview
Table 121. AstraZeneca Opioid Induced Side Effects Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Recent Developments
Table 124. AIKO Biotechnology Basic Information
Table 125. AIKO Biotechnology Opioid Induced Side Effects Treatment Product Overview
Table 126. AIKO Biotechnology Opioid Induced Side Effects Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. AIKO Biotechnology Business Overview
Table 128. AIKO Biotechnology Recent Developments
Table 129. Progenics Pharmaceuticals Basic Information
Table 130. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Overview
Table 131. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Progenics Pharmaceuticals Business Overview
Table 133. Progenics Pharmaceuticals Recent Developments
List of Figures
Figure 1. Product Picture of Opioid Induced Side Effects Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Induced Side Effects Treatment Market Size (M USD), 2024-2033
Figure 5. Global Opioid Induced Side Effects Treatment Market Size (M USD) (2020-2033)
Figure 6. Global Opioid Induced Side Effects Treatment Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Induced Side Effects Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Opioid Induced Side Effects Treatment Product Life Cycle
Figure 13. Opioid Induced Side Effects Treatment Sales Share by Manufacturers in 2024
Figure 14. Global Opioid Induced Side Effects Treatment Revenue Share by Manufacturers in 2024
Figure 15. Opioid Induced Side Effects Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Opioid Induced Side Effects Treatment Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Opioid Induced Side Effects Treatment Revenue in 2024
Figure 18. Industry Chain Map of Opioid Induced Side Effects Treatment
Figure 19. Global Opioid Induced Side Effects Treatment Market PEST Analysis
Figure 20. Global Opioid Induced Side Effects Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Opioid Induced Side Effects Treatment Market Size by Region
Figure 27. Global Opioid Induced Side Effects Treatment Market Size Market Share by Region (2020-2033)
Figure 28. Global Opioid Induced Side Effects Treatment Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Opioid Induced Side Effects Treatment Market Size (M USD) by Country
Figure 33. USA Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Opioid Induced Side Effects Treatment Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Opioid Induced Side Effects Treatment Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Opioid Induced Side Effects Treatment Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Opioid Induced Side Effects Treatment Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Opioid Induced Side Effects Treatment Market Size (M USD)by Type
Figure 40. North America Opioid Induced Side Effects Treatment Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Opioid Induced Side Effects Treatment Market Size (M USD) by Country
Figure 45. Germany Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Opioid Induced Side Effects Treatment Market Size (M USD) by Type
Figure 56. Europe Opioid Induced Side Effects Treatment Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Opioid Induced Side Effects Treatment Market Size (M USD) by Country
Figure 61. China Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Opioid Induced Side Effects Treatment Market Size (M USD) by Type
Figure 72. Asia-Pacific Opioid Induced Side Effects Treatment Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Opioid Induced Side Effects Treatment Market Size (M USD) by Country
Figure 77. Brazil Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Opioid Induced Side Effects Treatment Market Size (M USD) by Type
Figure 84. South America Opioid Induced Side Effects Treatment Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Opioid Induced Side Effects Treatment Market Size (M USD) by Country
Figure 89. Saudi Arabia Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Opioid Induced Side Effects Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Opioid Induced Side Effects Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Opioid Induced Side Effects Treatment Market Size (M USD) by Type
Figure 100. Middle East and Africa Opioid Induced Side Effects Treatment Market Size (M USD) by Application
Figure 101. Global Opioid Induced Side Effects Treatment Production Market Share by Region (2020-2025)
Figure 102. North America Opioid Induced Side Effects Treatment Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Opioid Induced Side Effects Treatment Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Opioid Induced Side Effects Treatment Production (K MT) Growth Rate (2020-2025)
Figure 105. China Opioid Induced Side Effects Treatment Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Opioid Induced Side Effects Treatment Market Size by Type (M USD)
Figure 108. Sales Market Share of Opioid Induced Side Effects Treatment by Type (2020-2033)
Figure 109. Sales Market Share of Opioid Induced Side Effects Treatment by Type in 2024
Figure 110. Market Size Share of Opioid Induced Side Effects Treatment by Type (2020-2033)
Figure 111. Market Size Share of Opioid Induced Side Effects Treatment by Type in 2024
Figure 112. Global Opioid Induced Side Effects Treatment Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Opioid Induced Side Effects Treatment Market Size by Application(M USD)
Figure 115. Global Opioid Induced Side Effects Treatment Market Share by Application
Figure 116. Global Opioid Induced Side Effects Treatment Sales Market Share by Application (2020-2033)
Figure 117. Global Opioid Induced Side Effects Treatment Sales Market Share by Application in 2024
Figure 118. Global Opioid Induced Side Effects Treatment Market Share by Application (2020-2033)
Figure 119. Global Opioid Induced Side Effects Treatment Market Share by Application in 2024
Figure 120. Global Opioid Induced Side Effects Treatment Sales Growth Rate by Application (2020-2033)